CPRX
Catalyst Pharmaceuticals Inc
31.50$
+0.0%
vs. previous close
Closing price · As of: Jul 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.1% | 13.8% | 14.3% | 12.7% | 12.6% | 15.0% | 15.3% | 12.7% | 20.4% | 17.1% | 17.1% | 16.2% | 17.7% | |
| 87.9% | 86.2% | 85.7% | 87.3% | 87.4% | 85.0% | 84.7% | 87.3% | 79.6% | 82.9% | 82.9% | 83.8% | 82.3% | |
| 4.0% | 81.5% | 1.8% | 2.6% | 2.4% | 2.6% | 2.7% | 2.7% | 3.0% | 1.8% | 1.2% | 1.8% | 1.9% | |
| 10.1% | 11.6% | 11.9% | 21.9% | 11.8% | 33.7% | 9.5% | 31.3% | 28.8% | 30.0% | 13.0% | 33.0% | 26.1% | |
| 41.0% | 122.4% | 48.0% | 59.8% | 43.2% | 45.5% | 40.4% | 42.5% | 34.3% | 38.3% | 42.4% | 34.8% | 37.5% | |
| 46.9% | -36.2% | 37.7% | 27.5% | 44.2% | 39.6% | 44.3% | 44.8% | 45.2% | 44.7% | 40.5% | 49.0% | 44.8% | |
| – | 0.3% | 1.5% | – | – | – | – | – | – | – | – | – | – | |
| 48.7% | -37.0% | 42.2% | 29.5% | 45.5% | 44.5% | 52.3% | 50.4% | 47.3% | 47.9% | 47.1% | 56.4% | 49.7% | |
| 10.8% | -7.1% | 10.7% | 5.9% | 12.2% | 10.4% | 12.9% | 10.3% | 11.7% | 12.3% | 12.6% | 13.7% | 12.6% | |
| 37.9% | -30.0% | 31.5% | 23.6% | 33.2% | 34.1% | 39.4% | 40.1% | 35.6% | 35.6% | 34.5% | 42.7% | 37.1% | |
| 57.3% | -28.4% | 50.5% | 39.1% | 53.2% | 51.8% | 59.0% | 57.1% | 53.7% | 54.2% | 53.4% | 63.0% | 56.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.